CIRM Funded Clinical Trials
AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205
Disease Area:
B cell cancers
Trial Sponsor:
Angiocrine Bioscience, Inc.
Trial Stage:
Phase 3
Trial Status:
Closed
Targeted Enrollment:
130
ClinicalTrials.gov ID:
